CIP
BSX icon

Convergence Investment Partners’s Boston Scientific BSX Stock Holding History

Convergence Investment Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,345
Closed -$209K – 250
2024
Q4 		$209K Buy
+2,345
New +$206K 0.05% 239
2018
Q2 		– Sell
-1,988
Closed -$54K – 397
2018
Q1 		$54K Buy
+1,988
New +$54K 0.01% 427

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Convergence Investment Partners's BSX Position: Q1 2025 in Review

Convergence Investment Partners sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 2,345 shares — an estimated $209K sold.

Convergence Investment Partners first reported a position in BSX in Q1 2018 and held it in 2 quarters. The position peaked at $209K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Convergence Investment Partners reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Convergence Investment Partners sold 2,345 Boston Scientific shares in Q1 2025, an estimated $209K.
  • Convergence Investment Partners first reported a position in Boston Scientific in Q1 2018 and held it in 2 quarters.
  • Convergence Investment Partners's Boston Scientific position peaked at $209K in Q4 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Convergence Investment Partners's 13F filing for Q1 2025, filed 6 May 2025.